Biotech Values

[Rocky3]

Question: Why are you bullish?

I think that everyone has grossly underestimated the quickness of the uptake of Rx's. I still am near the top end of all sale estimates this year - $10-12B. Depends on flat NRx until September when there sould be another kick in Rx numbers. Upside potential in EU sales. Sales will be huge next year too even with competition. Market should see huge earnings growth this year and next, and think that it will continue. I am still thinking a 15 p/e on $8 of earnings for 12/15 (or 20 times $6/sh for 12/14) is a minimum.

JMO.